A Post Approval Registry: ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
The purpose of this research study is to collect information about your treatment experience and any complications you may experience related to the ExAblate treatment. The ExAblate treatment itself or any other medical procedures you may receive are not part of this study. This is a safety follow-up study.
There are no regularly scheduled visits in this study. Although there are no study visits, you will still need to make the treatment visit and any other planned doctor visits that were planned for you by your treating doctor. At these visits, you will provide information about your experience with the ExAblate treatment. Your doctor will follow up with you as per care standards for your condition.
COH Protocol Number : 13238
ClinicalTrials.gov Number : NCT01834937
Principal Investigator : Wong, Jeffrey M.D.
Sponsor : InSightec, Inc.
BRIEF ELIGIBILITY CRITERIA :
Eligible Ages : >=18
Gender : Either
Prior Chemotherapy :
Brain Metastases :
Measurable Disease :